Recent News

• 03.11.2026 - Solventum to Participate in the 2026 KeyBanc Healthcare Forum
• 02.26.2026 - Solventum Reports Fourth Quarter 2025 Financial Results and Introduces 2026 Full-Year Guidance
• 02.03.2026 - Solventum to Report Fourth Quarter and Full Year Fiscal 2025 Earnings on February 26, 2026
• 12.23.2025 - Solventum Completes Acquisition of Acera Surgical
• 12.17.2025 - Global Expert Panel Publishes New Recommendations on Advanced Use of Closed Incision Negative Pressure Therapy
• 12.16.2025 - Solventum Earns Diamond Level HIRC Resiliency Badge, Demonstrating Best-In-Class Supply Chain Strength
• 11.25.2025 - Solventum to Participate in the 2025 Piper Sandler Healthcare Conference
• 11.20.2025 - Solventum Announces $1 Billion Share Repurchase Program
• 11.20.2025 - Solventum Announces Agreement to Acquire Acera Surgical

Recent Filings

• 02.27.2026 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.26.2026 - EX-99.1 EX-99.1
• 02.26.2026 - 8-K Current report
• 02.03.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.27.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 01.05.2026 - 4 Statement of changes in beneficial ownership of securities
• 12.16.2025 - 8-K Current report
• 12.16.2025 - EX-99.1 EX-99.1
• 12.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.02.2025 - 4 Statement of changes in beneficial ownership of securities